Ambiotis is the first Contract Research Organisation (CRO) working on the active resolution of the inflammatory process and making the proof of concept of innovative compounds.

The company offers a functional approach to the inflammatory process and the immunostimulation with an advanced set of in vivo and in vitro tests.